DUBLIN--(BUSINESS WIRE)--The "Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025)" report has been added to Research and Markets' offering.
"Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025)" provides a comprehensive study of global market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth.
The global market is highly competitive consisting of several large enterprises including Bayer AG, Roche Holding AG, Merck & Co., Inc. and Eli Lilly and Company. The competitive landscape of the respective market, along with the company profiles of leading players are discussed in detail.
The global CRC market would be driven by factors such as rising geriatric population, better reimbursement policies, growing number of obese people and others. However, the dynamics such as stringent regulatory norms, side effects of therapies and high cost of screening tests or drugs are expected to act as a threat for market's growth. Rising awareness regarding the incidence of CRC and importance of diagnosis has propelled higher compliance with regular tests.
Further, in order to harness the market potential, various companies are involved in developing lesser invasive and easy to use screening methods.
Key Topics Covered:
1. Overview
2. Global Colorectal Cancer Market
3. Regional Market
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles
- Bayer AG
- Eli Lilly and Company
- Merck & Co., Inc.
- Roche Holding AG
For more information about this report visit https://www.researchandmarkets.com/research/nzxch7/global_colorectal